-

Pearl Mini IVF Is Now RMA of San Diego

Rebranding Marks Expanded Scope of Services and Continued Commitment to Patients

SAN DIEGO--(BUSINESS WIRE)--IVI RMA North America, a leader in assisted reproductive technologies with over 22 IVF laboratories throughout the U.S. and Canada, today announced the rebrand of Pearl Mini IVF, a leading fertility clinic in San Diego. Pearl Mini IVF, which has been part of the IVI RMA network for four years, will now operate as RMA of San Diego. While continuing to offer mini-IVF services, RMA of San Diego will expand to include the full scope of reproductive medicine options offered at all IVI RMA North America clinics.

RMA of San Diego will continue to leverage IVI RMA’s advanced research capabilities and expand and enhance its services beyond its original focus on mini-IVF: a specialized type of IVF that uses minimal amounts of hormone stimulating medication to achieve a response from the ovaries. The clinic’s rebranding underscores its connection to IVI RMA’s full suite of fertility services, unparalleled patient success rates, medical and technological advancements in reproductive medicine, state-of-the-art facilities, and highly trained doctors.

“We are proud to introduce RMA of San Diego as the new brand for this clinic,” said Thomas Molinaro, M.D., Reproductive Endocrinologist and Chief Medical Officer at IVI RMA North America. “As one of nine IVI RMA locations in California and six in the Southern California region, RMA of San Diego reaffirms our commitment to providing industry-leading care and outcomes in the region.”

Dr. Scott Morin, West Coast Medical Director of IVI RMA North America and co-founder of RMA of Northern California, will oversee RMA of San Diego’s clinical operations. In this role, Dr. Morin will leverage his experience launching and growing RMA of Northern California to continue to serve the roughly 1 in 5 Californians who struggle with infertility, alongside Anastaysia Kosina, PA-C, Diana Tatsumi, PA, and Dr. Haley Genovese – who will join the practice in September.

Updated brand elements will be integrated across the RMA Network website, social channels, and patient communications.

About IVI RMA North America
IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 22 IVF laboratories and has helped women achieve pregnancies which have led to the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. Part of IVI RMA Global, one of the world's leading Reproductive Medicine groups committed to providing evidence-based fertility solutions with the greatest chance of success in the shortest time necessary to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 4,400 people across 190+ locations in 14 countries. Learn more at rmanetwork.com and ivirma.com.

Contacts

Media Contact:
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

IVI RMA North America


Release Versions

Contacts

Media Contact:
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

More News From IVI RMA North America

Boston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More Accessible

BOSTON--(BUSINESS WIRE)--Boston IVF, one of the nation’s leading reproductive service providers and a pioneer in IVF research, today announced new partnerships with Gaia, the first provider of value-based family building, and PatientFi, a modern, patient-friendly financing platform offering zero-interest plan options*, flexible monthly terms up to 84 months**, and financing that covers the entire fertility journey from treatments, and medications to labs, testing, and out-of-pocket expenses. Th...

IVI RMA North America Enters New York City Market through Partnership with Island Reproductive Services

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, today announced it has finalized a new partnership with Island Reproductive Services (“IRS” or “the Company”), the only reproductive medicine provider on Staten Island to have a fertility lab and offer comprehensive fertility treatment to its patients. The company’s partners, Dr. Eric Knochenhauer and Dr. Michael Traub, will retain an equity stake in the business and continue servi...

The 2025 World Fertility Awards Names First Legacy Award After IVI RMA Global Founder and Chairman, Prof. Antonio Pellicer

MADRID--(BUSINESS WIRE)--The inaugural World Fertility Awards (WFAs), presented by global media platform Pregnantish, has named its 2025 Legacy Award after Professor Antonio Pellicer, Co-Founder and Executive Chair of the Board of Directors for IVI RMA Global. Prof. Pellicer is a renowned IVF pioneer and one of the most influential figures in reproductive medicine. Recognizing his impact on the field, the eponymous 2025 Prof. Antonio Pellicer Legacy Award will be given to an individual whose sc...
Back to Newsroom